What role does Menopause Check play in Fruchtbarkeit?

The MyBody-X Menopause Check measures biomarkers such as FSH, AMH, and vitamin D, which can provide insight into hormonal status and ovarian reserve. In the context of fertility, it is not a fertility test – it merely indicates whether a woman is in perimenopause or menopause, which is naturally associated with declining fertility. A low AMH level may suggest reduced egg reserve, but it does not predict current fertility or pregnancy chances. The evidence is based on clinical hormone testing practice, not on randomized trials for fertility prediction. MyBody-X markets this as a 'menopause check', not a fertility test. Women trying to conceive should pursue specific fertility evaluations (e.g., cycle monitoring, tubal patency) with a physician. The test can serve as supplementary information but does not replace medical fertility diagnostics.